BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16482560)

  • 1. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.
    Hissar SS; Goyal A; Kumar M; Pandey C; Suneetha PV; Sood A; Midha V; Sakhuja P; Malhotra V; Sarin SK
    J Med Virol; 2006 Apr; 78(4):452-8. PubMed ID: 16482560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.
    Singh S; Gupta R; Malhotra V; Sarin SK
    Indian J Pathol Microbiol; 2010; 53(2):238-43. PubMed ID: 20551524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India.
    Verma V; Chakravarti A; Kar P
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):408-14. PubMed ID: 18455899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genotypes of hepatitis C virus: their relationship with risk factors, the severity of liver disease, and the serologic response].
    Alonso Alonso P; Orduña A; San Miguel A; Domínguez E; Gutiérrez P; Lorenzo B; Zarzosa P; Angel Bratos M; Rodríguez Torres A
    Med Clin (Barc); 1998 May; 110(18):681-6. PubMed ID: 9656219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India.
    Chaudhuri S; Das S; Chowdhury A; Santra A; Bhattacharya SK; Naik TN
    J Clin Virol; 2005 Jan; 32(1):38-46. PubMed ID: 15572005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype.
    Mihm S; Fayyazi A; Hartmann H; Ramadori G
    Hepatology; 1997 Mar; 25(3):735-9. PubMed ID: 9049227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
    Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
    J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
    Kumar D; Farrell GC; Fung C; George J
    Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
    Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
    Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.